ExpiresMarch 24, 2025
CME Provider: American Medical Association
Description of CME Course
The same medications and treatments are not universally effective for every patient. How do physicians better prescribe medication and treatments to patients? Is there a way to determine which medication will work better for a specific patient? This course will answer those questions by introducing you to the concept of Pharmacogenomics, in which simple DNA tests help predict how patients will respond to some of the most commonly prescribed medications. We will look at what Pharmacogenomics is, its importance, and how it is changing the landscape of health care.
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Colon and Rectal Surgery
Medical Genetics and Genomics
Physical Medicine and Rehabilitation
Psychiatry and Neurology
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
1. Define the concept of pharmacogenomics
2. Identify the importance of pharmacogenomics
3. Recognize the current landscape of pharmacogenomics
4. Describe the potential of pharmacogenomics
CME Credit Type
AMA PRA Category 1 Credit